TCIM
GILD icon

TIAA CREF Investment Management’s Gilead Sciences GILD Stock Holding History

TIAA CREF Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$465M Sell
7,158,951
-2,808,453
-28% -$187M 0.33% 59
2018
Q4 		$623M Sell
9,967,404
-273,990
-3% -$19.2M 0.49% 37
2018
Q3 		$791M Buy
10,241,394
+1,786,881
+21% +$135M 0.52% 37
2018
Q2 		$599M Buy
8,454,513
+1,147,961
+16% +$81.1M 0.4% 49
2018
Q1 		$551M Buy
7,306,552
+1,771,028
+32% +$141M 0.37% 59
2017
Q4 		$397M Sell
5,535,524
-132,038
-2% -$10M 0.26% 82
2017
Q3 		$459M Sell
5,667,562
-599,709
-10% -$45.9M 0.31% 66
2017
Q2 		$444M Buy
6,267,271
+509,260
+9% +$33.9M 0.31% 70
2017
Q1 		$391M Sell
5,758,011
-475,353
-8% -$33.4M 0.28% 76
2016
Q4 		$446M Sell
6,233,364
-2,337,784
-27% -$174M 0.33% 63
2016
Q3 		$678K Sell
8,571,148
-1,465,954
-15% -$119M 0.42% 54
2016
Q2 		$837M Sell
10,037,102
-943,688
-9% -$83.7M 0.64% 29
2016
Q1 		$1.01B Sell
10,980,790
-880,370
-7% -$79.4M 0.77% 20
2015
Q4 		$1.2B Buy
11,861,160
+166,053
+1% +$17.3M 0.9% 14
2015
Q3 		$1.15B Buy
11,695,107
+2,976
+0% +$331K 0.9% 13
2015
Q2 		$1.37B Sell
11,692,131
-2,065,681
-15% -$226M 0.97% 9
2015
Q1 		$1.35B Buy
13,757,812
+1,467,732
+12% +$149M 0.94% 7
2014
Q4 		$1.16B Sell
12,290,080
-2,436,151
-17% -$252M 0.81% 15
2014
Q3 		$1.57B Sell
14,726,231
-1,722,988
-10% -$169M 1.11% 7
2014
Q2 		$1.36B Sell
16,449,219
-1,054,297
-6% -$82.1M 0.95% 9
2014
Q1 		$1.24B Sell
17,503,516
-1,411,569
-7% -$111M 0.89% 8
2013
Q4 		$1.42B Sell
18,915,085
-365,049
-2% -$25.4M 1.02% 9
2013
Q3 		$1.21B Sell
19,280,134
-222,427
-1% -$13.3M 0.95% 9
2013
Q2 		$999M Buy
+19,502,561
New +$1.02B 0.81% 18

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TIAA CREF Investment Management's GILD Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Gilead Sciences (GILD) stake by 28% in Q1 2019, selling an estimated $187M and leaving 7,158,951 shares worth $465M. The position accounts for 0.33% of the portfolio, ranked #59.

TIAA CREF Investment Management first reported a position in GILD in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.57B in Q3 2014. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • TIAA CREF Investment Management held 7,158,951 shares of Gilead Sciences worth $465M as of Q1 2019.
  • TIAA CREF Investment Management sold 2,808,453 Gilead Sciences shares in Q1 2019, an estimated $187M.
  • Gilead Sciences made up 0.33% of TIAA CREF Investment Management's portfolio in Q1 2019, its #59 holding.
  • TIAA CREF Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Gilead Sciences position peaked at $1.57B in Q3 2014.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.